Biocryst Pharmaceuticals Inc. Live Stock Price Today, Share Analysis and Chart

Name: Biocryst Pharmaceuticals Inc.: Is Infosys Ltd. worth buying?
Item: Biocryst Pharmaceuticals Inc.
Rating: 1.29516675
Author: Trendlyne DVM scores

about

BioCryst Pharmaceuticals Inc is a biotechnology company involved mainly in the research and development of novel small-molecule drugs, to block key enzymes involved in infectious and inflammatory diseases. Biocryst's research is based on multiple sci...

7.08 0.18 (2.61%)

37.40% Fall from 52W High

3.7M

XNAS Volume

XNAS 14 Nov, 2025 4:30 PM (EST)

Board Meeting

The next board meeting for Biocryst Pharmaceuticals Inc. is on 19 Nov 2025 for the purpose of Jefferies Global Healthcare Conference See details

Not Eligible

Expensive Valuation

12.7 / 100

Technically Neutral

39.1 / 100

1Yr Price target upside is 179%

11 analysts

Biocryst Pharmaceuticals Inc Live Price Chart

Switch to TradingView

Loading Fundamental data..

Loading data..

Biocryst Pharmaceuticals Inc. Live Stock Price Today, Share Analysis and Chart

BioCryst Pharmaceuticals Inc is a biotechnology company involved mainly in the research and development of novel small-molecule drugs, to block key enzymes involved in infectious and inflammatory diseases. Biocryst's research is based on multiple sci...

37.40% Fall from 52W High

SWOT Analysis

Biocryst Pharmaceuticals Inc Live Price Chart